Mayer Bethany 4

What Happened

• Bethany Mayer, a director of Astera Labs, sold a total of 686 shares (six open-market transactions) on June 24, 2026 for aggregate proceeds of $270,999. The individual reported lots:
  • 54 shares at $393.86 — $21,268
  • 193 shares at a weighted avg $392.67 — $75,786 (prices ranged ~$392.15–$392.83)
  • 99 shares at a weighted avg $391.27 — $38,736 (prices ranged ~$391.13–$391.38)
  • 146 shares at a weighted avg $396.49 — $57,888 (prices ranged ~$396.07–$396.84)
  • 165 shares at a weighted avg $398.32 — $65,722 (prices ranged ~$398.00–$398.61)
  • 29 shares at $399.96 — $11,599
• These were sales (not purchases). Sales are often routine (e.g., diversification or liquidity) and do not by themselves indicate company outlook.

Key Details

• Transaction date: June 24, 2026; Form 4 filed June 26, 2026 (timely).
• Total shares sold: 686; total proceeds: $270,999.
• Several reported prices are weighted averages; the filing provides price ranges per lot and offers to disclose exact breakdowns on request.
• The sales were made pursuant to a Rule 10b5-1 trading plan adopted by Mayer on November 25, 2024.
• One lot (29 shares) is noted as owned directly by The Jantzen/Mayer Family 2002 Trust, of which Mayer is trustee; she disclaims beneficial ownership of those trust shares except to the extent of any pecuniary interest.
• Shares owned after the transaction are not shown in the summary provided here; see the filing for post-transaction ownership details.

Context

• Sales under 10b5-1 plans are pre-arranged and typically considered automatic, reducing their signal about insider sentiment.
• For retail investors, purchases tend to be more informative than routine sales; consider this trade as part of broader insider activity and company fundamentals.